Open Label, Dose Escalation Phase I Study of AZD2281

Clinical trial NCT00572364 · COMPLETED

Trial details

NCT number: NCT00572364
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Malignancies

Start date: 2007-11-01
Primary completion: 2009-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.